The AUGMENT Study: Lenalidomide in Indolent Lymphoma … Balance the Imbalance!
Publication date: Available online 11 October 2019Source: Hematology/Oncology and Stem Cell TherapyAuthor(s): Reyad Dada
Source: Hematology Oncology and Stem Cell Therapy - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Hematology | Lymphoma | Revlimid | Stem Cell Therapy | Stem Cells | Study